Literature DB >> 20812323

Can we trust docking results? Evaluation of seven commonly used programs on PDBbind database.

Dariusz Plewczynski1, Michał Łaźniewski, Rafał Augustyniak, Krzysztof Ginalski.   

Abstract

Docking is one of the most commonly used techniques in drug design. It is used for both identifying correct poses of a ligand in the binding site of a protein as well as for the estimation of the strength of protein-ligand interaction. Because millions of compounds must be screened, before a suitable target for biological testing can be identified, all calculations should be done in a reasonable time frame. Thus, all programs currently in use exploit empirically based algorithms, avoiding systematic search of the conformational space. Similarly, the scoring is done using simple equations, which makes it possible to speed up the entire process. Therefore, docking results have to be verified by subsequent in vitro studies. The purpose of our work was to evaluate seven popular docking programs (Surflex, LigandFit, Glide, GOLD, FlexX, eHiTS, and AutoDock) on the extensive dataset composed of 1300 protein-ligands complexes from PDBbind 2007 database, where experimentally measured binding affinity values were also available. We compared independently the ability of proper posing [according to Root mean square deviation (or Root mean square distance) of predicted conformations versus the corresponding native one] and scoring (by calculating the correlation between docking score and ligand binding strength). To our knowledge, it is the first large-scale docking evaluation that covers both aspects of docking programs, that is, predicting ligand conformation and calculating the strength of its binding. More than 1000 protein-ligand pairs cover a wide range of different protein families and inhibitor classes. Our results clearly showed that the ligand binding conformation could be identified in most cases by using the existing software, yet we still observed the lack of universal scoring function for all types of molecules and protein families.
Copyright © 2010 Wiley Periodicals, Inc.

Mesh:

Substances:

Year:  2010        PMID: 20812323     DOI: 10.1002/jcc.21643

Source DB:  PubMed          Journal:  J Comput Chem        ISSN: 0192-8651            Impact factor:   3.376


  105 in total

1.  Improving molecular docking through eHiTS' tunable scoring function.

Authors:  Orr Ravitz; Zsolt Zsoldos; Aniko Simon
Journal:  J Comput Aided Mol Des       Date:  2011-11-11       Impact factor: 3.686

2.  Computational fragment-based screening using RosettaLigand: the SAMPL3 challenge.

Authors:  Ashutosh Kumar; Kam Y J Zhang
Journal:  J Comput Aided Mol Des       Date:  2012-01-15       Impact factor: 3.686

Review 3.  Software for systems biology: from tools to integrated platforms.

Authors:  Samik Ghosh; Yukiko Matsuoka; Yoshiyuki Asai; Kun-Yi Hsin; Hiroaki Kitano
Journal:  Nat Rev Genet       Date:  2011-11-03       Impact factor: 53.242

4.  Molecular simulation methods in drug discovery: a prospective outlook.

Authors:  Xavier Barril; F Javier Luque
Journal:  J Comput Aided Mol Des       Date:  2011-12-08       Impact factor: 3.686

5.  Molecular docking simulations for macromolecularly imprinted polymers.

Authors:  David R Kryscio; Yue Shi; Pengyu Ren; Nicholas A Peppas
Journal:  Ind Eng Chem Res       Date:  2011-10-31       Impact factor: 3.720

Review 6.  From laptop to benchtop to bedside: structure-based drug design on protein targets.

Authors:  Lu Chen; John K Morrow; Hoang T Tran; Sharangdhar S Phatak; Lei Du-Cuny; Shuxing Zhang
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

7.  Lead Finder docking and virtual screening evaluation with Astex and DUD test sets.

Authors:  Fedor N Novikov; Viktor S Stroylov; Alexey A Zeifman; Oleg V Stroganov; Val Kulkov; Ghermes G Chilov
Journal:  J Comput Aided Mol Des       Date:  2012-05-09       Impact factor: 3.686

8.  FDA approved drugs complexed to their targets: evaluating pose prediction accuracy of docking protocols.

Authors:  Mohammed H Bohari; G Narahari Sastry
Journal:  J Mol Model       Date:  2012-05-08       Impact factor: 1.810

9.  Novel codon insert in HIV type 1 clade B reverse transcriptase associated with low-level viremia during antiretroviral therapy.

Authors:  Antoine Chaillon; Sara Gianella; Homero Vazquez; Caroline Ignacio; Adam C Zweig; Douglas D Richman; Davey M Smith
Journal:  AIDS Res Hum Retroviruses       Date:  2013-10-05       Impact factor: 2.205

Review 10.  A review of mathematical representations of biomolecular data.

Authors:  Duc Duy Nguyen; Zixuan Cang; Guo-Wei Wei
Journal:  Phys Chem Chem Phys       Date:  2020-02-26       Impact factor: 3.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.